By competitive association with miR-200, lncRNA-ATB can upregulate ZEB1 and ZEB2 to affect HCC metastasis and invasion, and promote post-metastasis proliferation via IL-11 and STAT3 [200]. Here, ZEB2 is linked to hepatocellular carcinoma.